Torax Medical gets close to Italian HTA verdict on GORD device
This article was originally published in Clinica
Executive Summary
The Italian health technology assessment (HTA) agency, Agenas, has stopped short of issuing guidance on the use of a minimally-invasive device to treat gastro-oesophageal reflux disease (GORD), due to a lack of appropriate evidence.